In the realm of cardiovascular health, understanding nuanced risk factors is paramount. Lipoprotein(a), or Lp(a), is a significant independent risk factor for heart attack, stroke, aortic stenosis, and more. Elevated Lp(a) is the most common genetic lipidemia, affecting more than 1.4 billion individuals globally and 1 in 5 individuals in the US (those with an Lp(a) level of > 50 mg/dL or > 125 nmol/L).

To dive deeper into Lp(a), we’ve put together a three-part podcast mini-series that delves into this crucial topic, featuring experts and insights that can empower both healthcare professionals and the general public.

Lp(a): Closer to Home Than You Think

Guests Kathy Byrne, MSN, CRNP, CCRN.,and Lisa Maher, DNP, ARNP, FNP-BC, FPCNA, describe the most common genetic dyslipidemia–elevated lipoprotein (a), or Lp(a). The discussion includes testing for Lp(a)–especially for family members, and others who may be at risk. Resources for patients and HCPs are also part of the conversation.

Lurking Lp(a): Hiding Just Below the Surface

While Lp(a) levels are generally hereditary in nature, other factors can cause elevated levels. Learn about current guidelines-directed medical therapies, and how guests Lisa Maher, DNP, ARNP, FNP-BC, FPCNA, and Kathy Byrne, MSN, CRNP, CCRN apply these guidelines to clinical practice.

We’re All Responsible for Lp(a)

Guest Cindy Lamendola, MSN, NP, FAHA, FPCNA, describes the impacts of elevated Lp(a) on the body. Current clinical trials and the necessity of including diverse participants are described, as well as the importance of keeping Lp(a) front of mind no matter our role as healthcare professionals.

Be sure to complete the post-test after listening to each podcast and receive 0.25 CE contact hours per episode!